Latest stories on PLRZ
Polyrizon Raises $4 Million in Registered Direct Offering and Private Placement
TipRanks24 · bearishgeneral
Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
GlobeNewswire28 · bearishgeneral
Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
StockTitan28 · bearishgeneral
Polyrizon prices $4M registered direct offering
Seeking Alpha28 · bearishgeneral
Polyrizon announces $4.0M registered direct offering
The Fly24 · bearishgeneral
Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
Business Insider28 · bearishgeneral
Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
GlobeNewswire28 · bearishgeneral
Polyrizon completes all five U.S. site contracts for Nasarix allergy study
The Fly63 · neutralproduct/pr
Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study
StockTitan63 · neutralproduct/pr
PLRZ Trading Strategies for Polyrizon Ltd Stock
Barchart50 · neutralgeneral
Polyrizon Finalizes U.S. Clinical Site Network for NASARIX Allergy Study
TipRanks63 · neutralproduct/pr
Polyrizon completes clinical site network for NASARIX study
The Fly63 · neutralproduct/pr
Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment
Business Insider63 · neutralproduct/pr
Polyrizon Shareholders Approve New Executive Compensation Policy on July 13, 2026
TipRanks50 · neutralgeneral
Polyrizon Clears Key Safety Milestone for NASARIX Allergy Nasal Spray
TipRanks68 · bullishproduct/pr
Polyrizon shares climb after NASARIX passes key biocompatibility testing (PLRZ)
InvestorsHub63 · neutralproduct/pr
PLRZ Advances Toward Human Trials as NASARIX Clears All Biocompatibility Hurdles
MarketChameleon67 · bullishproduct/pr
Polyrizon Wins Central IRB Nod for First NASARIX Allergy Blocker Trial
TipRanks67 · bullishproduct/pr
Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial | PLRZ Stock News
StockTitan63 · neutralproduct/pr
Polyrizon Announces U.S. Publication of Mucoadhesive Nasal Drug Delivery Patent
TipRanks56 · neutralproduct/pr
Polyrizon receives U.S. patent publication notice for nasal drug delivery platform
Seeking Alpha63 · neutralproduct/pr
Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform | PLRZ Stock News
StockTitan63 · neutralproduct/pr
Polyrizon Launches Key Human Study to Advance NASARIX Allergy Blocker Toward FDA Pathway
TipRanks63 · neutralproduct/pr